123
Participants
Start Date
July 31, 2013
Primary Completion Date
January 31, 2014
Study Completion Date
March 31, 2014
SkinPlus-Hyal®
The Injector will administer to the eligible subject the Study Device and Comparator Device (Comparator or Study Device) respectively to the left and right nasolabial fold in a randomized manner.
Restylane®
The Injector will administer to the eligible subject the Study Device and Comparator Device (Comparator or Study Device) respectively to the left and right nasolabial fold in a randomized manner.
Seoul national university Bundang Hospital, Seongnam-si
Seoul National University Hospital, Jongno-gu
HumanTissueKorea Ltd.
UNKNOWN
Seoul National University Hospital
OTHER